Numa Health Market Research Report
Company Overview
- Name: Numa Health International
- Mission: No information is available about the mission.
- Founded: June 2019
- Founders:
- Thomas Schmit, Co-founder and Chief Executive Officer
- Dr. Kamyar Hedayat, Co-founder and Chief of Science
- Key People:
- Thomas Schmit, Chief Executive Officer
- Kamyar Hedayat, Vice-President in charge of Science and Innovation
- Maël, Chief Product Officer
- Emmanuelle, Chief Business Officer
- Headquarters:
- 6 rue Eugène Thomas, 17000, La Rochelle, France
- Additional location: 24, Boulevard Pasteur, Paris, 75015 Paris
- Number of Employees: 15
- Revenue: No information is available about revenue.
- Known For: Developing customized health solutions to measure, understand, and naturally and sustainably act on health. Their solutions cater to employee health prevention, sports performance optimization, and predicting pathologies for health professionals.
Products
- Solutions for Predictive Health:
- High-Level Description: These are tailor-made tools integrated into healthcare pathways, utilizing multi-source data collection to optimize patient care decisions.
- Key Features:
- Quality decision-making based on optimized synthesis from patient data.
- Designed by and for physicians, promoting preventive healthcare and integrating medical practices.
- Lifestyle and health recommendations based on unique blood test interpretations and organism function modeling.
Recent Developments
- Recent Developments:
- 2019: Numa Health was founded, and launched its first platform for medical doctors.
- 2020: Raised its first funding round accumulating 1.3 million euros. Published a clinical study on a predictive risk score for severe COVID-19 in association with the Hospital of La Rochelle.
- 2022: Strengthened the team with hires in development, marketing, sales, and data science.
- 2023: Completed a Series A funding round, raising 4 million euros with investments from Groupe Inovie, Groupe Pasteur Mutualité, and RGreen Invest.
- Continuous publishing of scientific research and involvement in scientific partnerships.
- New Products Launched:
- No new products have been explicitly mentioned.
- New Features Added:
- The predictive risk score for severe COVID-19 developed in conjunction with the Hospital of La Rochelle.
- New Partnerships:
- Collaboration with the Groupe Pasteur Mutualité to provide Numa Health solutions to its members.
- Engagement in scientific partnerships for research and innovation development.
Numa Health remains committed to being a mission-driven company under France's PACTE law, focusing on social and environmental commitments. As a certified Innovative Young Firm (JEI), it continues to excel in R&D, maintaining independence in its operations.
